Here are the 424B prospectus supplements from WORK Medical Technology Group LTD (WOK) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 424B covers the supplement that carries the terms of a priced offering, so if you follow WOK and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full WOK filings page.
WORK Medical Technology Group LTD is launching an at-the-market offering of up to $200,000,000 of Class A ordinary shares through AC Sunshine Securities LLC as sales agent. The company will pay a 3.5% commission on shares sold, and would receive up to approximately $192,820,000 in estimated net proceeds if the full amount is issued, to be used for working capital and general corporate purposes.
The Class A shares trade on the NASDAQ Capital Market under the symbol WOK, and there were 960,012 Class A and 75,925 Class B ordinary shares outstanding as of November 20, 2025. Because each Class B share has 20 votes, the chief operating officer currently controls about 50.43% of the voting power, and selling more than 21,489 new Class A shares would reduce this below 50%.
The filing highlights that investors are buying shares in a Cayman Islands holding company whose operations are conducted through PRC subsidiaries, and details extensive legal, regulatory, and geopolitical risks tied to operating in China and potential U.S. trading restrictions under the HFCA Act.